Allostatic load in bipolar disorder: Implications for pathophysiology and treatment

Neuroscience and Biobehavioral Reviews

Volumn 32, Issue 4, 2008, Pages 675-692

  Kapczinski, Flavio ^a   Vieta, Eduard ^b,c,d   Andreazza, Ana Cristina ^f   Frey, Benicio N ^e   Gomes, Fabiano A ^a   Tramontina, Juliana ^a   Kauer Sant'Anna, Marcia ^f   Grassi Oliveira, Rodrigo ^g   Post, Robert M ^h  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d HARVARD UNIVERSITY   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^h PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Allostatic load; Bipolar disorder; Clinical morbidity; Cognitive impairment; Comorbidity; Kindling; Sensitization; Stress

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ATYPICAL ANTIPSYCHOTIC AGENT; CATECHOL METHYLTRANSFERASE; MIFEPRISTONE; MOOD STABILIZER; SEROTONIN TRANSPORTER;

ALLOSTASIS; AMYGDALOID NUCLEUS; BIPOLAR DISORDER; BRAIN REGION; CIRCADIAN RHYTHM; COGNITIVE DEFECT; COMORBIDITY; COPING BEHAVIOR; DISEASE COURSE; ENVIRONMENTAL STRESS; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; NEUROPROTECTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW;

ALLOSTASIS; BIPOLAR DISORDER; BRAIN; CIRCADIAN RHYTHM; EMOTIONS; ENVIRONMENT; HUMANS;

EID: 40149096962     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2007.10.005     Document Type: Review

References (210)

1. Adler C.M., Levine A.D., DelBello M.P., and Strakowski S.M. Changes in gray matter volume in patients with bipolar disorder. Biological Psychiatry 58 (2005) 151-157
2. Altshuler L.L., Bartzokis G., Grieder T., Curran J., Jimenez T., Leight K., Wilkins J., Gerner R., and Mintz J. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biological Psychiatry 48 (2000) 147-162
3. Andreazza A.C., Cassini C., Rosa A.R., Leite M.C., de Almeida L.M., Nardin P., Cunha A.B., Cereser K.M., Santin A., Gottfried C., Salvador M., Kapczinski F., and Gonçalves C.A. Serum S100B and antioxidant enzymes in bipolar patients. Journal of Psychiatric Research 41 (2007) 523-529
4. Andreazza A.C., Frey B.N., Erdtmann B., Salvador M., Rombaldi F., Santin A., Gonçalves C.A., and Kapczinski F. DNA damage in bipolar disorder. Psychiatry Research (2007) (June 19 [Eletronic publication ahead of print])
5. Angst F., Stassen H.H., Clayton P.J., and Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. Journal of Affective Disorders 68 (2002) 167-181
6. Arnow B.A. Relationships between childhood maltreatment, adult health and psychiatric outcomes and medical utilization. Journal of Clinical Psychiatry 65 Suppl. 12 (2004) 10-15
7. Baez S., Segura-Aguilar J., Widersten M., Johansson A.S., and Mannervik B. Glutathione transferases catalyse the detoxication of oxidized metabolites(o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochemical Journal 324 (1997) 25-28
8. Bairey Merz C.N., Dwyer J., Nordstrom C.K., Walton K.G., Salerno J.W., and Schneider R.H. Psychological stress and cardiovascular disease: pathophysiological links. Behavioral Medicine 27 (2002) 141-147
9. Belmaker R.H. Bipolar disorder. New England Journal of Medicine 351 (2004) 476-486
10. Benes F.M., Matzilevich D., Burke R.E., and Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Molecular Psychiatry 11 (2006) 241-251
11. Berk M. Oxidative stress in bipolar disorder: a double blind randomized placebo controlled trial of N-acetyl cysteine as glutathione precursor. Bipolar Disorders 9 s 1 (2007) 21
12. Berk M., Dodd S., Kauer-Sant'Anna M., Malhi G.S., Bourin M., Kapczinski F., and Norman T. Dopamine dysregulation syndrome: implications for dopamine hypothesis of bipolar disorder. Acta Psychiarica Scandinavica 116 Suppl. 424 (2007) 1-9
13. Berk M., Hallam K.T., and McGorry P.D. The potential utility of a staging model as a course specifier: a bipolar disorder perspective. Journal of Affective Disorders 100 (2007) 279-281
14. Berman S.B., and Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. Journal of Neurochemistry 73 (1999) 1127-1137
15. Beyer J.L., Kuchibhatla M., Payne M.E., Moo-Young M., Cassidy F., Macfall J., and Krishnan K.R. Hippocampal volume measurement in older adults with bipolar disorder. American Journal of Geriatric Psychiatry 12 (2004) 613-620
16. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., Goldman R.S., Hoptman M.J., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J.P., Kunz M., Chakos M., Cooper T.B., and Lieberman J.A. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biological Psychiatry 52 (2002) 701-707
17. Blumberg H.P., Fredericks C., Wang F., Kalmar J.H., Spencer L., Papademetris X., Pittman B., Martin A., Peterson B.S., Fulbright R.K., and Krystal J.H. Preliminary evidence for persistent abnormalities in amygdala volumes in adolescents and young adults with bipolar disorder. Bipolar Disorder 7 (2005) 570-576
18. Brambilla P., Harenski K., Nicoletti M., Sassi R.B., Mallinger A.G., Frank E., Kupfer D.J., Keshavan M.S., and Soares J.C. MRI investigation of temporal lobe structures in bipolar patients. Journal of Psychiatric Research 37 (2003) 287-295
19. Bremner J.D. Long-term effects of childhood abuse on brain and neurobiology. Child and Adolescent Psychiatric Clinics of North America 12 (2003) 271-292
20. Breunis M.N., Kupka R.W., Nolen W.A., Suppes T., Denicoff K.D., Leverich G.S., Post R.M., and Drexhage H.A. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biological Psychiatry 53 (2003) 157-165
21. Brouilette S., Singh R.K., Thompson J.R., Goodall A.H., and Samani N.J. White cell telomere length and risk of premature myocardial infarction. Arteriosclerosis Thrombosis and Vascular Biology 23 (2003) 842-846
22. Brown S.M., Henning S., and Wellman C.L. Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cerebral Cortex 15 (2005) 1714-1722
23. Burdick K.E., Funke B., Goldberg J.F., Bates J.A., Jaeger J., Kucherlapati R., and Malhotra A.K. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disorder 9 (2007) 370-376
24. Cahill L., Prins B., Weber M., and McGaugh J.L. Beta-adrenergic activation and memory for emotional events. Nature 371 (1994) 702-704
25. Carney C.P., and Jones L.E. Medical comorbidity in women and men with bipolar disorders: A population-based controlled study. Psychosomatic Medicine 68 (2006) 684-691
26. Carter C.J. Multiple genes and factors associated with bipolar disorder converge on growth factor and tress activated kinase pathways controlling translation initiation: implications for oligodentdrocyte viability. Neurochemistry International 50 (2007) 461-490
27. Caspi A., and Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nature Reviews Neuroscience 7 (2006) 583-590
28. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
29. Cecil K.M., DelBello M.P., Morely R., and Strakowski S.M. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disorder 4 (2002) 357-365
30. Cervantes P., Gelber S., Kin F.N., Nair V.N., and Schwartz G. Circadian secretion of cortisol in bipolar disorder. Journal of Psychiatry and Neuroscience 26 (2001) 411-416
31. Chang K., Adleman N., Dienes K., Barnea-Goraly N., Reiss A., and Ketter T. Decreased N-acetylaspartate in children with familial bipolar disorder. Biological Psychiatry 53 (2003) 1059-1065
32. Chen C.H., Lennox B., Jacob R., Calder A., Lupson V., Bisbrown-Chippendale R., Suckling J., and Bullmore E. Explicit and implicit facial affect recognition in manic and depressed states of bipolar disorder: a functional magnetic resonance imaging study. Biological Psychiatry 59 (2006) 31-39
33. Chen G., Bower K.A., Ma C., Fang S., Thiele C.J., and Luo J. Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB Journal 18 (2004) 1162-1164
34. Compas B.E. Psychobiological processes of stress and coping: implications for resilience in children and adolescents-comments on the papers of Romeo & McEwen and Fisher et al. Annals of the New York Academy of Sciences 1094 (2006) 226-234
35. Coyle J.T., and Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38 (2003) 157-160
36. Craddock N., and Forty L. Genetics of affective (mood) disorders. European Journal of Human Genetics 14 (2006) 660-668
37. Craddock N., Daniels J., Roberts E., Rees M., McGuffin P., and Owen M.J. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. American Journal of Medical Genetics 60 (1995) 322-324
38. Cunha A.B., Frey B.N., Andreazza A.C., Goi J.D., Rosa A.R., Goncalves C.A., Santin A., and Kapczinski F. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neuroscience Letters 398 (2006) 215-219
39. Czeh B., Muller-Keuker J.I., Rygula R., Abumaria N., Hiemke C., Domenici E., and Fuchs E. Chronic social stress inhibits cell proliferation in the Adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology 32 (2006) 1490-1503
40. Deicken R.F., Fein G., and Weiner M.W. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. American Journal of Psychiatry 152 (1995) 915-918
41. DelBello M.P., Zimmerman M.E., Mills N.P., Getz G.E., and Strakowski S.M. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disorder 6 (2004) 43-52
42. Dickerson F., Stallings C., Origoni A., Boronow J., and Yolken R. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (2007) 952-955
43. Dickstein D.P., Milham M.P., Nugent A.C., Drevets W.C., Charney D.S., Pine D.S., and Leibenluft E. Frontotemporal alterations in pediatric bipolar disorder: results of a voxel-based morphometry study. Archives of General Psychiatry 62 (2005) 734-741
44. Dranovsky A., and Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biological Psychiatry 59 (2006) 1136-1143
45. Duchen M.R. Mitochondria and calcium: from cell signalling to cell death. Journal of Physiology 529 (2000) 57-68
46. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., and Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 6917-6922
47. Eley T.C., Sugden K., Corsico A., Gregory A.M., Sham P., McGuffin P., Plomin R., and Craig I.W. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Molecular Psychiatry 9 (2004) 908-915
48. Eriksen H.R., and Ursin H. Sensitization and subjective health complaints. Scandinavian Journal of Psychology 43 (2002) 189-196
49. Evans D.L., and Nemeroff C.B. The dexamethasone suppression test in mixed bipolar disorder. American Journal of Psychiatry 140 (1983) 615-617
50. Frazier J.A., Chiu S., Breeze J.L., Makris N., Lange N., Kennedy D.N., Herbert M.R., Bent E.K., Koneru V.K., Dieterich M.E., Hodge S.M., Rauch S.L., Grant P.E., Cohen B.M., Seidman L.J., Caviness V.S., and Biederman J. Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. American Journal of Psychiatry 162 (2005) 1256-1265
51. Frazier J.A., Ahn M.S., DeJong S., Bent E.K., Breeze J.L., and Giuliano A.J. Magnetic resonance imaging studies in early-onset bipolar disorder: a critical review. Harvard Review of Psychiatry 13 (2005) 125-140
52. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., Dal-Pizzol F., Kapczinski F., and Quevedo J. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. Journal of Psychiatry and Neuroscience 31 (2006) 326-332
53. Frey B.N., Andreazza A.C., Kunz M., Gomes F.A., Quevedo J., Salvador M., Gonçalves C.A., and Kapczinski F. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (2007) 283-285
54. Frey B.N., Stanley J.A., Nery F.G., Monkul E.S., Nicoletti M.A., Chen H.-H., et al. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disorder 9 Suppl. 1 (2007) 119-127
55. Gibbons J.L. Cortisol secretion rate in depressive illness. Archives of General Psychiatry 10 (1964) 572-575
56. Gibbons J.L., and McHugh P.R. Plasma cortisol in depressive illness. Journal of Psychiatric Research 1 (1962) 162-171
57. Glover D.A. Allostatic load in women with and without PTSD symptoms. Annals of the New York Academy of Sciences 1071 (2006) 442-447
58. Godwin C.D., Greenberg L.B., and Shukla S. Predictive value of the dexamethasone suppression test in mania. American Journal of Psychiatry 141 (1984) 1610-1612
59. Goswami U., Sharma A., Khastigir U., Ferrier I.N., Young A.H., Gallagher P., Thompson J.M., and Moore P.B. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. British Journal of Psychiatry 188 (2006) 366-373
60. Gould T.D., and Manji H.K. Signaling networks in the pathophysiology and treatment of mood disorders. Journal of Psychosomatic Research 53 (2002) 687-697
61. Green E.K., Raybould R., Macgregor S., Hyde S., Young A.H., O'Donovan M.C., Owen M.J., Kirov G., Jones L., Jones I., and Craddock N. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. British Journal of Psychiatry 188 (2006) 21-25
62. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18 (2001) 685-716
63. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. Journal of Neurochemistry 97 (2006) 1634-1658
64. Halliwell B., and Gutteridge J.M. Free radicals in Biology and Medicine. third ed (1999), Clarendon, Oxford
65. Harmer C.J., Grayson L., and Goodwin G.M. Enhanced recognition of disgust in bipolar illness. Biological Psychiatry 51 (2002) 298-304
66. Hashimoto K., Shimizu E., and Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Research Reviews 45 (2004) 104-114
67. Hauser P., Matochik J., Altshuler L.L., Denicoff K.D., Conrad A., Li X., and Post R.M. MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. Journal of Affective Disorders 60 (2000) 25-32
68. Hillegers M.H., Reichart C.G., Wals M., Verhulst F.C., Ormel J., Nolen W.A., and Drexhage H.A. Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents. European Neuropsychopharmacology 17 (2006) 394-399
69. Ho B.C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., and Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Archives of General Psychiatry 63 (2006) 731-740
70. Huang T.L., and Lin F.C. High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (2007) 370-372
71. Iwamoto K., Bundo M., and Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Human Molecular Genetics 14 (2005) 241-253
72. Jackson A., Cavanagh J., and Scott J. A systematic review of manic and depressive prodromes. Journal of Affective Disorders 74 (2003) 209-217
73. Jacobs N., Kenis G., Peeters F., Derom C., Vlietinck R., and van Os J. Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Archives of General Psychiatry 63 (2006) 989-996
74. Jay T.M., Rocher C., Hotte M., Naudon L., Gurden H., and Spedding M. Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases. Neurotoxicity Research 6 (2004) 233-244
75. Karlamangla A.S., Singer B.H., McEwen B.S., Rowe J.W., and Seeman T.E. Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. Journal of Clinical Epidemiology 55 (2002) 696-710
76. Karlamangla A.S., Singer B.H., Greendale G.A., and Seeman T.E. Increase in epinephrine excretion is associated with cognitive decline in elderly men: MacArthur studies of successful aging. Psychoneuroendocrinology 30 (2005) 453-460
77. Karlamangla A.S., Singer B.H., and Seeman T.E. Reduction in allostatic load in older adults is associated with lower all-cause mortality risk: MacArthur studies of successful aging. Psychosomatic Medicine 68 (2006) 500-507
78. Kato T., Takahashi S., Shiori T., et al. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. Journal of Affective Disorders 31 (1994) 125-133
79. Kato T., Shioiri T., Murashita J., Hamakawa H., Takahashi Y., Inubushi T., and Takahashi S. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychological Medicine 25 (1995) 557-566
80. Kauer-Sant'Anna, M., Yatham, L.N., Tramontina, J., et al., 2008. Emotional Memory in Bipolar Disorder. British Journal of Psychiatry, submitted for publication.
81. Kaufman J., Yang B.Z., Douglas-Palumberi H., Houshyar S., Lipschitz D., Krystal J.H., and Gelernter J. Social supports and serotonin transporter gene moderate depression in maltreated children. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 17316-17321
82. Kaufman J., Yang B.Z., Douglas-Palumberi H., Grasso D., Lipschitz D., Houshyar S., Krystal J.H., and Gelernter J. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biological Psychiatry 59 (2006) 673-680
83. Kawada Y., Hattori M., Dai X.Y., and Nanko S. Possible association between monoamine oxidase A gene and bipolar affective disorder. American Journal of Human Genetics 56 1 (1995) 335-336
84. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., and Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Archives of General Psychiatry 62 (2005) 529-535
85. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Kim Y.H., and Yoon J.S. Interactions Between Life Stressors and Susceptibility Genes (5-HTTLPR and BDNF) on Depression in Korean Elders. Biological Psychiatry (2007) (May 3 [Eletronic publication ahead of print])
86. Kim Y., Laposky A.D., Bergmann B.M., and Turek F.W. Repeated sleep restriction in rats leads to homeostatic and allostatic responses during recovery sleep. Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 10697-10702
87. Knijff E.M., Breunis M.N., van Geest M.C., Kupka R.W., Ruwhof C., de Wit H.J., Nolen W.A., and Drexhage H.A. A relative resistance of T cells to dexamethasone in bipolar disorder. Bipolar Disorder 8 (2006) 740-750
88. Krishnan R.R., Maltbie A.A., and Davidson J.R. Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms. American Journal of Psychiatry 140 (1983) 203-205
89. Kuloglu M., Ustundag B., Atmaca M., Canatan H., Tezcan E., and Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar desorder. Cell Biochemistry and Function 20 (2002) 171-175
90. Kupfer D.J. The increasing medical burden in bipolar disorder. Journal Of American Medical Association 293 (2005) 2528-2530
91. Kupka R.W., Hillegers M.H.J., Nolen W.A., Breunis N., and Drexhage H.A. Immunological aspects of bipolar disorder. Acta Neuropsychiatrica 12 (2000) 86-90
92. Kupka R.W., Nolen W.A., Post R.M., McElroy S.L., Altshuler L.L., Denicoff K.D., Frye M.A., Keck Jr. P.E., Leverich G.S., Rush A.J., Suppes T., Pollio C., and Drexhage H.A. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biological Psychiatry 51 (2002) 305-311
93. Kupka R.W., Breunis M.N., Knijff E., Ruwhof C., Nolen W.A., and Drexhage H.A. Immune activation, steroid resistancy and bipolar disorder. Bipolar Disorder 4 Suppl. 1 (2002) 73-74
94. Lan N.C., Chen C.H., and Shih J.C. Expression of functional human monoamine oxidase A and B cDNAs in mammalian cells. Journal of Neurochemistry 52 5 (1989) 1652-1654
95. Lawrence N.S., Williams A.M., Surguladze S., Giampietro V., Brammer M.J., Andrew C., Frangou S., Ecker C., and Phillips M.L. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biological Psychiatry 55 (2004) 578-587
96. Leverich G.S., McElroy S.L., Suppes T., Keck Jr. P.E., Denicoff K.D., Nolen W.A., Altshuler L.L., Rush A.J., Kupka R., Frye M.A., Autio K.A., and Post R.M. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biological Psychiatry 51 (2002) 288-297
97. Linkowski P., Kerkhofs M., van Onderbergen A., Hubain P., Copinschi G., L'Hermite-Baleriaux M., Leclercq R., Brasseur M., Mendlewicz J., and van Cauter E. The 24-h profiles of cortisol, prolactin, and growth hormone secretion in mania. Archives of General Psychiatry 51 (1994) 616-624
98. Liu H.C., Yang Y.Y., Chou Y.M., Chen K.P., Shen W.W., and Leu S.J. Immunologic variables in acute mania of bipolar disorder. Journal of Neuroimmunology 150 (2004) 116-122
99. Lochhead R.A., Parsey R.V., Oquendo M.A., and Mann J.J. Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry. Biological Psychiatry 55 (2004) 1154-1162
100. Lupien S.J., Evans A., Lord C., Miles J., Pruessner M., Pike B., and Pruessner J.C. Hippocampal volume is as variable in young as in older adults: implications for the notion of hippocampal atrophy in humans. Neuroimage 34 (2007) 479-485
101. Lyons D.M. Stress, depression, and inherited variation in primate hippocampal and prefrontal brain development. Psychopharmacology Bulletin 36 (2002) 27-43
102. MacDonald M.L., Naydenov A., Chu M., Matzilevich D., and Konradi C. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disorder 8 (2006) 255-264
103. Machado-Vieira R., Andreazza A.C., Viale C.I., Zanatto V., Cereser Jr. V., Vargas R.S., Kapczinski F., Portela L.V., Souza D.O., Salvador M., and Gentil V. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neuroscience Letters 421 (2007) 33-36
104. Machado-Vieira R., Dietrich M.O., Leke R., Cereser V.H., Zanatto V., Kapczinski F., Souza D.O., Portela L.V., and Gentil V. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biological Psychiatry 61 (2007) 142-144
105. Maker H.S., Weiss C., Silides D.J., and Cohen G. Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. Journal of Neurochemistry 36 (1981) 589-593
106. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 20 (2000) 9104-9110
107. Malhi G.S., Lagopoulos J., Owen A.M., and Yatham L.N. Bipolaroids: functional imaging in bipolar disorder. Acta Psychiatrica Scandinavia 422 Suppl. (2004) 46-54
108. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., and Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. American Journal of Psychiatry 159 (2002) 652-654
109. Mandelli L., Serretti A., Marino E., Pirovano A., Calati R., and Colombo C. Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. International Journal of Neuropsychopharmacology 10 (2007) 437-447
110. Manji H.K., Quiroz J.A., Payne J.L., Singh J., Lopes B.P., Viegas J.S., and Zarate C.A. The underlying neurobiology of bipolar disorder. World Psychiatry 2 (2003) 136-146
111. Maroun M. Stress reverses plasticity in the pathway projecting from the ventromedial prefrontal cortex to the basolateral amygdala. European Journal of Neuroscience 24 (2006) 2917-2922
112. Martinez-Aran A., Vieta E., Reinares M., Colom F., Torrent C., Sanchez-Moreno J., Benabarre A., Goikolea J.M., Comes M., and Salamero M. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. American Journal of Psychiatry 161 (2004) 262-270
113. Martinez-Aran A., Vieta E., Torrent C., Sanchez-Moreno J., Goikolea J.M., Salamero M., Malhi G.S., Gonzalez-Pinto A., Daban C., Alvarez-Grandi S., Fountoulakis K., Kaprinis G., Tabares-Seisdedos R., and Ayuso-Mateos J.L. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disorder 9 (2007) 103-113
114. McClung C.A. Circadian genes, rhythms and the biology of mood disorders. Pharmacology and Therapeutics 114 (2007) 222-232
115. McClure D.J. The diurnal variation of plasma cortisol levels in depression. Journal of Psychosomatic Research 10 (1966) 189-195
116. McCubrey J.A., Lahair M.M., and Franklin R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxidants and Redox Signaling 8 (2006) 1775-1789
117. McDonald C., Marshall N., Sham P.C., Bullmore E.T., Schulze K., Chapple B., Bramon E., Filbey F., Quraishi S., Walshe M., and Murray R.M. Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. American Journal of Psychiatry 163 (2006) 478-487
118. McElroy S.L., Altshuler L.L., Suppes T., Keck Jr. P.E., Frye M.A., Denicoff K.D., Nolen W.A., Kupka R.W., Leverich G.S., Rochussen J.R., Rush A.J., and Post R.M. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. American Journal of Psychiatry 158 (2001) 420-426
119. McEwen B.S. Protective and damaging effects of stress mediators. New England Journal of Medicine 338 (1998) 171-179
120. McEwen B.S. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 22 (2000) 108-124
121. McEwen B.S. The neurobiology and neuroendocrinology of stress. Implications for post-traumatic stress disorder from a basic science perspective. Psychiatric Clinics of North America 25 (2002) 469-494
122. McEwen B.S. Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging. Metabolism 52 Suppl. 2 (2003) 10-16
123. McEwen B.S. Mood disorders and allostatic load. Biological Psychiatry 54 (2003) 200-207
124. McEwen B.S. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Annals of the New York Academy of Sciences 1032 (2004) 1-7
125. McEwen B.S. Structural plasticity of the adult brain: how animal models help us understand brain changes in depression and systemic disorders related to depression. Dialogues in Clinical Neuroscience 6 (2004) 119-133
126. McEwen B.S. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism 55 Suppl. 2 (2006) S20-S23
127. McEwen B.S., and Stellar E. Stress and the individual. Mechanisms leading to disease. Archives of Internal Medicine 153 (1993) 2093-2101
128. McEwen B.S., and Wingfield J.C. The concept of allostasis in biology and biomedicine. Hormones and Behavior 43 (2003) 2-15
129. McIntyre R.S., Konarski J.Z., Misener V.L., and Kennedy S.H. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Annals of Clinical Psychiatry 17 (2005) 83-93
130. McIntyre R.S., Soczynska J.K., Beyer J.L., Woldeyohannes H.O., Law C.W., Miranda A., Konarski J.Z., and Kennedy S.H. Medical comorbidity in bipolar disorder: reprioritizing unmet needs. Current Opinion in Psychiatry 20 (2007) 406-416
131. Moghaddam B., and Jackson M. Effect of stress on prefrontal cortex function. Neurotoxicity Research 6 (2004) 73-78
132. Monkul E.S., Malhi G.S., and Soares J.C. Anatomical MRI abnormalities in bipolar disorder: do they exist and do they progress?. Australian and New Zealand Journal of Psychiatry 39 (2005) 222-226
133. 13C] glucose infusion. Journal of Neurochemistry 77 (2001) 347-350
134. Muller D.J., de Luca V., Sicard T., King N., Strauss J., and Kennedy J.L. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. British Journal of Psychiatry 189 (2006) 317-323
135. Nothen M.M., Eggermann K., Albus M., Borrmann M., Rietschel M., Korner J., Maier W., Minges J., Lichtermann D., Franzek E., Weigelt B., Knapp M., and Propping P. Association analysis of the monoamine oxidase A gene in bipolar affective disorder by using family-based internal controls. American Journal of Human Genetics 57 (1995) 975-978
136. O'Brien S.M., Scully P., Scott L.V., and Dinan T.G. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. Journal of Affective Disorders 90 (2006) 263-267
137. Öngur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 13290-13295
138. Otto M.W., Simon N.M., Wisniewski S.R., Miklowitz D.J., Kogan J.N., Reilly-Harrington N.A., Frank E., Nierenberg A.A., Marangell L.B., Sagduyu K., Weiss R.D., Miyahara S., Thase M.E., Sachs G.S., Pollack M.H., and STEP-BD Investigators. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. British Journal of Psychiatry 189 (2006) 20-25
139. Ozcan M.E., Gulec M., Ozerol E., Polat R., and Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. International Clinical Psychopharmacology 19 (2004) 89-95
140. Ozelius L., Hsu Y.P., Bruns G., Powell J.F., Chen S., Weyler W., Utterback M., Zucker D., Haines J., Trofatter J.A., et al. Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism. Genomics 3 1 (1988) 53-58
141. Padmos R.C., Bekris L., Knijff E.M., Tiemeier H., Kupka R.W., Cohen D., Nolen W.A., Lernmark A., and Drexhage H.A. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biological Psychiatry 56 (2004) 476-482
142. Parsian A., and Todd R.D. Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data. American Journal of Medical Genetics 74 (1997) 475-479
143. Pearlson G.D., Barta P.E., Powers R.E., Menon R.R., Richards S.S., Aylward E.H., Federman E.B., Chase G.A., Petty R.G., and Tien A.Y. Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biological Psychiatry 41 (1997) 1-14
144. Pezawas L., Verchinski B.A., Mattay V.S., Callocott J.H., Kolachana B.S., Straub R.E., Egan M.F., Meyer-Lindenberg A., and Weinberger D.R. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Journal of Neuroscience 24 (2004) 10099-10102
145. Phillips M.L., and Vieta E. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophrenia Bulletin 33 (2007) 893-904
146. Platman S.R., Hilton J.G., Koss M.C., and Kelly W.G. Production of cortisol in patients with manic-depressive psychosis treated with Lithium Carbonate. Diseases of the Nervous System 32 (1971) 542-544
147. Post R.M. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. Journal of Psychiatric Research (2007) (January 17 [Eletronic publication ahead of print])
148. Post R.M., and Leverich G.S. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Development and Psychopathology 18 (2006) 1181-1211
149. Preisig M., Bellivier F., Fenton B.T., Baud P., Berney A., Courtet P., Hardy P., Golaz J., Leboyer M., Mallet J., Matthey M.L., Mouthon D., Neidhart E., Nosten-Bertrand M., Stadelmann-Dubuis E., Guimon J., Ferrero F., Buresi C., and Malafosse A. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. American Journal of Psychiatry 157 (2000) 948-955
150. Rajkowska G., Halaris A., and Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry 49 (2001) 741-752
151. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., Wagh U.V., Debsikdar V.B., and Mahadik S.P. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research 121 (2003) 109-122
152. Ray R., and Shah A.M. NADPH oxidase and endothelial cell function. Clinical Science 109 (2005) 217-226
153. Regenold W.T., Thapar R.K., Marano C., et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. Journal of Affective Disorders 70 (2002) 19-26
154. Robinson L.J., and Ferrier I.N. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disorder 8 (2006) 103-116
155. Robinson L.J., Thompson J.M., Gallagher P., Goswami U., Young A.H., Ferrier I.N., and Moore P.B. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. Journal of Affective Disorders 93 (2006) 105-115
156. Romeo R.D., and McEwen B.S. Stress and the adolescent brain. Annals of the New York Academy of Sciences 1094 (2006) 202-214
157. Rosa A., Peralta V., Cuesta M.J., Zarzuela A., Serrano F., Martinez-Larrea A., and Fananas L. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. American Journal of Psychiatry 161 (2004) 1110-1112
158. Rosa A.R., Frey B.N., Andreazza A.C., Cereser K.M., Cunha A.B., Quevedo J., Santin A., Gottfried C., Goncalves C.A., Vieta E., and Kapczinski F. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neuroscience Letters 407 (2006) 146-150
159. Rowe M.K., and Chuang D.M. Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Reviews in Molecular Medicine 6 (2004) 1-18
160. Rubinsztein D.C., Leggo J., Goodburn S., Walsh C., Jain S., and Paykel E.S. Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. Human Molecular Genetics 5 6 (1996) 779-782
161. Rybakowski J.K., Borkowska A., Czerski P.M., Skibinska M., and Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disorder 5 (2003) 468-472
162. Sachar E.J., Hellman L., Fukushima D.K., and Gallagher T.F. Cortisol production in mania. Archives of General Psychiatry 26 (1972) 137-139
163. Saretzki G., and Von Zglinicki T. Replicative aging, telomeres, and oxidative stress. Annals of the New York Academy of Sciences 959 (2002) 24-29
164. Sassi R.B., Stanley J.A., Axelson D., Brambilla P., Nicoletti M.A., Keshavan M.S., Ramos R.T., Ryan N., Birmaher B., and Soares J.C. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. American Journal of Psychiatry 162 (2005) 2109-2115
165. Schmider J., Lammers C.H., Gotthardt U., Dettling M., Holsboer F., and Heuser I.J. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biological Psychiatry 38 (1995) 797-802
166. Schulkin J. Allostasis: a neural behavioral perspective. Hormones and Behavior 43 (2003) 21-27
167. Seeman T.E., McEwen B.S., Singer B.H., Albert M.S., and Rowe J.W. Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. Journal of Clinical Endocrinology and Metabolism 82 (1997) 2458-2465
168. Seeman T.E., McEwen B.S., Rowe J.W., and Singer B.H. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 4770-4775
169. Seeman T.E., Crimmins E., Huang M.H., Singer B., Bucur A., Gruenewald T., Berkman L.F., and Reuben D.B. Cumulative biological risk and socio-economic differences in mortality: MacArthur studies of successful aging. Social Science and Medicine 58 (2004) 1985-1997
170. Serrano F., and Klann E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Research and Reviews 3 (2004) 431-443
171. Shao L., Young L.T., and Wang J.F. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biological Psychiatry 58 (2005) 879-884
172. Sher L. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior. Scientific World Journal 6 (2006) 1398-1404
173. Sierra P., Livianos L., Arques S., Castello J., and Rojo L. Prodromal symptoms to relapse in bipolar disorder. Australian and New Zealand Journal of Psychiatry 41 (2007) 385-391
174. Signoretti S., Marmarou A., Tavazzi B., Dunbar J., Amorini A.M., Lazzarino G., and Vagnozzi R. The protective effect of cyclosporine A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury. Journal of Neurotrauma 21 (2004) 1154-1167
175. Simon N.M., Smoller J.W., McNamara K.L., Maser R.S., Zalta A.K., Pollack M.H., Nierenberg A.A., Fava M., and Wong K.K. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biological Psychiatry 60 (2006) 432-435
176. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress and glucocorticoids affect the expression of BDNF and NT-3 MRNAs in the hippocampus. Journal of Neuroscience 15 (1995) 1768-1777
177. Spiliotaki M., Salpeas V., Malitas P., Alevizos V., and Moutsatsou P. Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients. Psychoneuroendocrinology 31 (2006) 748-760
178. Sterling P., and Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S., and Reason J. (Eds). Handbook of Life Stress, Cognition and Health (1988), Wiley, New York 629-649
179. Stewart J.A. The detrimental effects of allostatic load as a measure of cumulative stress. Journal of Physiological Anthropology 25 (2006) 133-145
180. Stokes K.Y., Clanton E.C., Russel J.M., Ross C.R., and Granger D.N. NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation Research 88 (2001) 499-505
181. Sun X., Wang J.F., Tseng M., and Young L.T. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. Journal of Psychiatry and Neuroscience 31 (2006) 189-196
182. Swaab D.F., Bao A.M., and Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Research and Reviews 4 (2005) 141-194
183. Swann A.C., Stokes P.E., Casper R., Secunda S.K., Bowden C.L., Berman N., Katz M.M., and Robins E. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiarica Scandinavica 85 (1992) 270-274
184. Takuma K., Baba A., and Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Progress in Neurobiology 72 (2004) 111-127
185. Taylor S.E., Way B.M., Welch W.T., Hilmert C.J., Lehman B.J., and Eisenberger N.I. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biological Psychiatry 60 (2006) 671-676
186. Teicher M.H., Andersen S.L., Polcari A., Anderson C.M., Navalta C.P., and Kim D.M. The neurobiological consequences of early stress and childhood maltreatment. Neuroscience and Biobehavioral Reviews 27 (2003) 33-44
187. Thompson J.M., Gallagher P., Hughes J.H., Watson S., Gray J.M., Ferrier I.N., and Young A.H. Neurocognitive impairment in euthymic patients with bipolar affective disorder. British Journal of Psychiatry 186 (2005) 32-40
188. Tramontina J., Frey B.N., Andreazza A.C., Zandona M., Santin A., and Kapczinski F. Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Molecular Psychiatry 12 (2007) 230-231
189. Tsai S.Y., Chen K.P., Yang Y.Y., Chen C.C., Lee J.C., Singh V.K., and Leu S.J. Activation of indices of cell-mediated immunity in bipolar mania. Biological Psychiatry 45 (1999) 989-994
190. Tsai S.J., Yu Y.W., Chen T.J., Chen J.Y., Liou Y.J., Chen M.C., and Hong C.J. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neuroscience Letters 338 (2003) 123-126
191. Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrikov V., and Rachmanova V. Electron microscopy of oligodendroglia in severe mental illness. Brain Research Bulletin 55 (2001) 597-610
192. Vieta E., and Phillips M.L. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophrenia Bulletin 33 (2007) 886-892
193. Vieta E., Gasto C., Martinez-De-Osaba M.J., Nieto E., Canto T.J., Otero A., and Vallejo J. Prediction of depressive relapse in remitted bipolar patients using corticotrophin-releasing hormone challenge test. Acta Psychiarica Scandinavica 95 (1997) 205-211
194. Vieta E., Martinez-De-Osaba M.J., Colom F., Martinez-Aran A., Benabarre A., and Gasto C. Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients. Psychological Medicine 29 (1999) 971-978
195. Vonk R., Schot A.C., Kahn R.S., Nolen W.A., and Drexhage H.A. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?. Biological Psychiatry 62 (2006) 135-140
196. Vyas A., Mitra R., Shankaranarayana Rao B.S., and Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. Journal of Neuroscience 22 (2002) 6810-6818
197. Vyas A., Bernal S., and Chattarji S. Effects of chronic stress on dendritic arborization in the central and extended amygdala. Brain Research 965 (2003) 290-294
198. Wadee A.A., Kuschke R.H., Wood L.A., Berk M., Ichim L., and Maes M. Serological observations in patients suffering from acute manic episodes. Human Psychopharmacology 17 (2002) 175-179
199. Walter M.F., Jacob R., Jeffers B., Ghadanfar M., Preston G., Buch J., and Mason R. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease a longitudinal analysis of the PREVENT study. Journal of the American College of Cardiology 44 10 (2004)
200. Walz J.C., Andreazza A.C., Frey B.N., Cacilhas A.A., Cereser K.M., Cunha A.B., Weyne F., Stertz L., Santin A., Goncalves C.A., and Kapczinski F. Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neuroscience Letters 415 (2007) 87-89
201. Watson S., Gallagher P., Ritchie J.C., Ferrier I.N., and Young A.H. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. British Journal of Psychiatry 184 (2004) 496-502
202. Watson S., Thompson J.M., Ritchie J.C., Ferrier I.N., and Young A.H. Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function. Bipolar Disorder 8 (2006) 85-90
203. Wichers M., Kenis G., Jacobs N., Mengelers R., Derom C., Vlietinck R., and van Os J. The BDNF Val(66)Met×5-HTTLPR×child adversity interaction and depressive symptoms: An attempt at replication. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics (2007)
204. Winsberg M.E., Sachs N., Tate D.L., Adalsteinsson E., Spielman D., and Ketter T.A. Decreased dorsolateral prefrontal N-acetylaspartate in bipolar disorder. Biological Psychiatry 47 (2000) 475-481
205. Yildiz-Yesiloglu A., and Ankerst D.P. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (2006) 969-995
206. Young A.H., Gallagher P., Watson S., Del-Estal D., Owen B.M., and Ferrier I.N. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 29 (2004) 1538-1545
207. Yurgelun-Todd D.A., Gruber S.A., Kanayama G., Killgore W.D., Baird A.A., and Young A.D. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disorder 2 (2000) 237-248
208. Zarate Jr. C.A., Tohen M., Land M., and Cavanagh S. Functional impairment and cognition in bipolar disorder. Psychiatry Quarterly 71 (2000) 309-329
209. Zimmermann U.S., Blomeyer D., Laucht M., and Mann K.F. How gene-stress-behavior interactions can promote adolescent alcohol use: the roles of predrinking allostatic load and childhood behavior disorders. Pharmacology Biochemistry and Behavior 86 (2006) 246-262
210. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., and Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. Journal of Psychiatric Research 34 (2001) 171-181